About
ATMP Sweden
ATMP Sweden Association
Membership
Newsletter
ATMPs
What are ATMPs?
Vad är ATMPs?
Swedish ATMP
ATMP Map
ATMP Companies
Immunotherapies
Related Organisations
Initiatives
Current Initiatives
AdBIOPRO
AI Characterisation
ATMP Sweden Association
CCRM Nordic
Cell & Gene Therapy Sweden
digiSafe
EATRIS ATMP nod
GeneNova
Hospital ATMP Centers
IndiCell
Innovation Hub
NextGenNK
Research School
StartCell
SWECARNET
Testa Center
VOG Cell
Finalized Initiatives
ATMP2030
CAMP
Swelife-ATMP
News
ATMP Development
Resources
Commercial aspects
Dictionary
Job Opportunities
Logistics Cookbook
Patent/IP Support
Reports
Training Opportunities
Process Map
Clinical Process Map
Commercial Process Map
Manufacture Process Map
Regulatory Process Map
Product Developer Process Map
ATMP Regulatory Guide
How to use this guide
Definition and idea
Risk assessment and early documentation
Advanced Therapy Medicinal Products (ATMPs)
Clinical Trials
Hospital Exemption
The ATMP Classes
Guides and Documents
Abbreviations
Links
Events
Annual Conferences
ATMP Sweden 2025 Conference
ATMP Sweden 2024 Malmö
ATMP Sweden Webinars
Upcoming Events
Seminar
Workshop
Training
Course
Conference
Contact
About
ATMP Sweden
ATMP Sweden Association
Membership
Newsletter
ATMPs
What are ATMPs?
Vad är ATMPs?
Swedish ATMP
ATMP Map
ATMP Companies
Immunotherapies
Related Organisations
Initiatives
Current Initiatives
AdBIOPRO
AI Characterisation
ATMP Sweden Association
CCRM Nordic
Cell & Gene Therapy Sweden
digiSafe
EATRIS ATMP nod
GeneNova
Hospital ATMP Centers
IndiCell
Innovation Hub
NextGenNK
Research School
StartCell
SWECARNET
Testa Center
VOG Cell
Finalized Initiatives
ATMP2030
ATMP2030 Partners
Implementation in Healthcare
Sjukhusapoteksfunktioner
Juridiska frågor
Ökad kompetens
Kliniska läkemedelsprövningar
Kvalificering av kliniker
Patient- och närståendesamverkan
Uppföljning
Industrial development
CCRM-nod
National Coordination
Kommunikationsplattform
Kartläggning
Sustainable continuation
Educational efforts
CAMP
CAMP Projects
Artery regeneration
Amniotic derived cell therapy
Automated manufacturing
Extracellular vesicles
GMP pluripotent derivatives
Mesenchymal Stromal Cells
Next gen CAR-T
Pre-GMP facility
Tissue-Engineered Skin
Vecura Manufacture
Approach
CAMP Partners
CAMP Organisation
Program Office
General Assembly
Executive Board
Swelife-ATMP
Swelife-ATMP Projects
SDP1 Regulatory
SDP2 Stem Cells
SDP3 Health Economy
SDP4 Gene therapy
SDP5 SWECARNET
Swelife-ATMP Partners
Swelife-ATMP Organisation
News
ATMP Development
Resources
Commercial aspects
Dictionary
Job Opportunities
Logistics Cookbook
Patent/IP Support
Reports
Training Opportunities
Process Map
Clinical Process Map
Commercial Process Map
Manufacture Process Map
Regulatory Process Map
Product Developer Process Map
ATMP Regulatory Guide
How to use this guide
Definition and idea
Risk assessment and early documentation
Advanced Therapy Medicinal Products (ATMPs)
Clinical Trials
Hospital Exemption
The ATMP Classes
Combined ATMPs (cATMP)
Gene Therapy Medicinal Products (GTMPs)
Somatic Cell Therapy Medical Products (sCTMPs)
Tissue Engineered Products (TEPs)
Guides and Documents
Abbreviations
Links
Events
Annual Conferences
ATMP Sweden 2025 Conference
ATMP Sweden 2024 Malmö
ATMP Sweden Webinars
Upcoming Events
Seminar
Workshop
Training
Course
Conference
Contact
Search
Partner login
Become a partner
ATMP Sweden
ATMP development
Resources
ATMP Regulatory Guide
The ATMP classes
The ATMP classes
Gene therapy medicinal products (GTMPs)
Somatic cell therapy medicinal products (sCTMPs)
Tissue engineered products (TEPs)
Combined ATMPs (cATMP)
